Table 2.
Assessment of efficacy
| Time intervals | Clinical examinations |
|---|---|
| At baseline | Glycosylated hemoglobin (HbA1c) |
| Liver function tests (AST, ALT, ALP and bilirubin) | |
| Renal function tests (urea and creatinine) | |
| Cardiovascular function test (creatinine) | |
| Hematogram | |
| Fasting blood glucose | |
| Postprandial blood glucose | |
| Serum C-peptide | |
| Serum bilirubin | |
| Total leukocyte count | |
| First and second month follow-up visit | Liver function test (AST, ALT, ALP and bilirubin) |
| Renal function test (urea and creatinine) | |
| Fasting blood glucose | |
| Postprandial blood glucose | |
| Serum bilirubin | |
| On completion of treatment (third month) | HbA1c |
| Liver function test (AST, ALT, ALP and bilirubin) | |
| Renal function test (urea and creatinine) | |
| Hematogram | |
| Fasting blood glucose | |
| Postprandial blood glucose | |
| Serum C-peptide | |
| Serum bilirubin | |
| Total leukocyte count |